Compare Baroda BNP Paribas Health and Wellness Fund vs ICICI Prudential Healthcare Fund
Baroda BNP Paribas Health and Wellness Fund
EquitySectoral-Pharma
ICICI Prudential Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.7
2.07
NAV
₹10.37
₹44.81
Fund Started
09 Jun 2025
25 Jun 2018
Fund Size
₹487.35 Cr
₹6861.20 Cr
Exit Load
Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
Exit load of 1% if redeemed within 15 days.
1 Year
4.10%
2.11%
3 Year
-
19.35%
5 Year
-
13.95%
Equity
97.06%
98.91%
Cash
0.16%
1.09%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 8.58% |
Torrent Pharmaceuticals Ltd. | 7.88% |
Divi's Laboratories Ltd. | 7.82% |
Ipca Laboratories Ltd. | 6.13% |
Laurus Labs Ltd. | 6.09% |
Lupin Ltd. | 5.79% |
Apollo Hospitals Enterprise Ltd. | 5.28% |
Fortis Healthcare Ltd. | 3.98% |
Dr. Lal Pathlabs Ltd. | 3.47% |
Mankind Pharma Ltd. | 3.34% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.49% |
Dr. Reddy's Laboratories Ltd. | 9.73% |
Cipla Ltd. | 5.79% |
Biocon Ltd. | 5.33% |
Mankind Pharma Ltd. | 5.04% |
Alkem Laboratories Ltd. | 4.81% |
Medplus Health Services Ltd. | 4.31% |
Cohance Lifesciences Ltd. | 4.06% |
Divi's Laboratories Ltd. | 3.78% |
Syngene International Ltd. | 3.50% |
Name
-
-
Start Date
-
-
Description
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
09 Jun 2025
25 Jun 2018
